Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
Clinical trial NCT02555371 · COMPLETED
Trial details
- NCT number
- NCT02555371
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-07
- Primary completion
- 2019-07-24
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.